Results 81 to 90 of about 825 (170)

Blonanserin Induced Hypokinesia and Tardive Dyskinesia

Journal of Molecular Biomarkers & Diagnosis, 2015
A 27 year old male diagnosed with psychosis, who was treated with Risperidone followed by aripiprazole was reported to present with adverse effects. Hence the therapy was changed to Blonanserin. It is a dopamine serotonin antagonist which has got fewer propensities to cause tardive dyskinesia (TD) than conventional antipsychotics and other atypical ...
Saraswathy GR, Virupaksha HS
openaire   +1 more source

A case of neuroleptic malignant syndrome following cardiac surgery

Archives of Clinical and Experimental Surgery, 2017
Neuroleptic malignant syndrome (NMS) is rare but sometimes causes life-threatening conditions. We report the case of a 53-year-old male patient who developed NMS following cardiac surgery. He was diagnosed with schizophrenia and pre- scribed blonanserin,
Atsushi Tamura, Hiroko Nakata, Takamichi Yoshizaki, Sho Kusadokoro   +3 more
doaj   +1 more source

Efficacy and safety of blonanserin in the treatment of treatment-resistant schizophrenia

Sichuan jingshen weisheng
BackgroundIn schizophrenia， a subset of patients may progress to treatment-resistant schizophrenia owing to inadequate response to standard antipsychotic therapies， resulting in profound impairments in cognitive and social functioning alongside a ...
Zhang Ruilin, Tang Jiayu, Dai Fei, Sun Junwei   +3 more
doaj   +1 more source

Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities

Neuropsychiatric Disease and Treatment, 2016
Kosuke Okazaki, Manabu Makinodan, Kazuhiko Yamamuro, Tomoyo Takata, Toshifumi Kishimoto Department of Psychiatry, Nara Medical University School of Medicine, Kashihara, JapanObjective: Methamphetamine (MA) use has recently been associated with high ...
Okazaki K, Makinodan M, Yamamuro K, Takata T, Kishimoto T   +4 more
doaj  

Table_1_Improvement of social functioning in patients with first-episode schizophrenia using blonanserin treatment: a prospective, multi-centre, single-arm clinical trial.docx

ObjectivesThis clinical trial primarily aimed to investigate the effects of blonanserin on social functioning in patients with first-episode schizophrenia.MethodsIn this prospective, multi-centre, single-arm clinical trial study, blonanserin (flexible ...
Chengcheng Pu (8422074), Tianqi Gao (6458588), Lina Wang (44695), Hong Deng (115865), Fude Yang (442803), Haiyun Li (444679), Jianhua Sheng (7379495), Zhening Liu (151207), Shaohua Hu (392578), Xin Yu (124814), Bin Wu (138543), Xijin Wang (5337419)   +11 more
core   +1 more source

Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Naïve First-Episode Schizophrenia

Neuropsychiatric Disease and Treatment
WanHeng Hu,1– 4,* BingJie Huang,1– 4,* XiaoDong Guo,1– 4 XiaoLin Yin,1– 4 XiangHe Wang,1– 4 YunFei Ji,1– 4 Yue Zheng,1– 4 TianQi Gao,1– 4 Chuan Shi,1– 4 Xin Yu,1– 4 Chengcheng Pu1– 4 1Department of Psychiatry, Peking University Sixth ...
Hu W, Huang B, Guo X, Yin X, Wang X, Ji Y, Zheng Y, Gao T, Shi C, Yu X, Pu C   +10 more
doaj  

Montmorillonite and Laponite Clay Materials for the Solidification of Lipid-Based Formulations for the Basic Drug Blonanserin: In Vitro and in Vivo Investigations

, 2018
Solid-state lipid-based formulations offer great potential for the improved oral delivery of poorly water-soluble drugs. This study investigates the use of the high-surface-area clay materials, montmorillonite and laponite, as solid carriers for lipid ...
Cuyckens, Filip, René Holm (1417582), Nicky Thomas, Thomas, N., Cis van Looveren, Rao, Shasha, van Looveren, Cis, Tahnee J. Dening, Filip Cuyckens, René Holm, Cuyckens, F., Nicky Thomas (763134), Rao, S., Shasha Rao (541058), Dening, Tahnee J., Thomas, Nicky, Van Looveren, C., Dening, T.J., Filip Cuyckens (2331970), Tahnee J. Dening (5545520), Holm, R., Prestidge, Clive A., Holm, René, Shasha Rao, Clive A. Prestidge, Cis van Looveren (5628293), Clive A. Prestidge (541062)   +26 more
core   +1 more source

High Solubility Crystalline Pharmaceutical Forms of Blonanserin

, 2016
Blonanserin (BLN) is an antipsychotic drug having poor aqueous solubility. In continuation of our preliminary work (CrystEngComm 2012, 14, 2367−2372), the aim of this study was to improve physicochemical properties of the drug, such as solubility ...
D. Maddileti (1628509), Ashwini Nangia (1400761), Battini Swapna (1628512)   +2 more
core   +1 more source

Comparative study of treatment continuation using second-generation antipsychotics in patients with schizophrenia or schizoaffective disorder

Neuropsychiatric Disease and Treatment, 2011
Takaharu Azekawa, Shizuko Ohashi, Akira ItamiShioiri Mental Clinic, Yokosuka-shi, Kanagawa-ken, JapanBackground: Effectiveness of a drug is a key concept dependent on efficacy, safety, and tolerability.
Azekawa T, Ohashi S, Itami A
doaj  

Blonanserin

Drugs in R & D, 1999
openaire   +2 more sources